Anti-infective compounds for Yersinia

Read full text
Authors: Kumar D. Gahlot, Matthew S. Francis, Jyoti M. Gurung
Cited by: 1
References: 261

Abstract

Abstract Yersinia is a genus of bacteria that includes several species known to cause diseases in humans and animals. We explore developments in anti-bacterial compounds to counteract Yersinia infections, focusing on both traditional antibiotic therapies and novel strategies targeting virulence factors, host-pathogen interactions, and vaccine development. This review evaluates current strategies for the treatment and management of Yersinia infections, outlining key challenges and emerging opportunities for improved clinical outcomes.

Fields of Study & Subjects

Yersinia bacterium plague ectoparasites research Leprosy Research and Treatment Vibrio bacteria research studies

Publication details

Journal / source
Sustainable Microbiology
Publisher
Oxford University Press (OUP)
Volume
3
Issue
2
Pages
qvag014–qvag014
Publication date
1 January 2026
Language
EN